Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

The Effect of Traumatic Diagnostic Lumbar Puncture in De Novo Pediatric Acute Myeloid Leukemia - a Report from the Children's Oncology Group

Donna L Johnston, MD FRCPC, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Richard Aplenc, MD PhD, William G Woods, MD, Soheil Meshinchi, MD PhD, Alan S. Gamis, MD MPH

Blood (2016) 128 (22): 4016.

https://doi.org/10.1182/blood.V128.22.4016.4016

Published: 2016

Journal Articles

Outcome of Pediatric Patients with Acute Myeloid Leukemia and -5/5q-Abnormalities Enrolled On Five Children's Oncology Group Acute Myeloid Leukemia Treatment Protocols

Donna L Johnston, MD, FRCPC, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Betsy A. Hirsch, PhD, Nyla A. Heerema, PhD, Yaddanapudi Ravindranath, MBBS, William G. Woods, MD, Beverly J. Lange, MD, Alan S. Gamis, MD, MPH, Susana C. Raimondi, PhD

Blood (2012) 120 (21): 1414.

https://doi.org/10.1182/blood.V120.21.1414.1414

Published: 2012

Journal Articles

A Phase I/II Trial of Lenalidomide and RCHOP (R2CHOP) in Patients with Newly Diagnosed Diffuse Large B -Cell (DLBCL) and Follicular Grade 3 Lymphoma.

Grzegorz S. Nowakowski, Betsy LaPlant, Thomas Habermann, David J Inwards, Patrick L Johnston, MD, PhD, Clive S. Zent, MD, Craig B. Reeder, MD, Thomas E Witzig, MD

Blood (2009) 114 (22): 1669.

https://doi.org/10.1182/blood.V114.22.1669.1669

Published: 2009

Journal Articles

MYC Translocations Are Associated with Poor Overall Survival in DLBCL Patients in Both the Chemotherapy and Immunochemotherapy Eras.

Ahmet Dogan, MD, PhD, Matthew J Maurer, MS, William R Macon, MD, David J Inwards, MD, Ivana N Micallef, MD, Patrick L Johnston, MD, PhD, Mark Law, Kay Ristow, Thomas E Witzig, MD, James R Cerhan, MD, PhD, Thomas M Habermann, MD

Blood (2009) 114 (22): 443.

https://doi.org/10.1182/blood.V114.22.443.443

Published: 2009

Journal Articles

Absolute Lymphocyte Count Assessed During Routine Follow-up Is a Risk Factor for Relapse Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Patients with Diffuse Large B-Cell Lymphoma.

Luis Porrata, MD, David J Inwards, Stephen M Ansell, Ivana Micallef, Patrick L Johnston, MD, PhD, William Hogan, MD, Svetomir Markovic

Blood (2009) 114 (22): 4359.

https://doi.org/10.1182/blood.V114.22.4359.4359

Published: 2009

Journal Articles

A Risk Adapted Approach Utilizing Plerixafor in Autologous Peripheral Blood Stem Cell Mobilization.

Ivana Micallef, Stephen M Ansell, Francis Buadi, David Dingli, M.D., PhD., Angela Dispenzieri, Dennis Gastineau, Morie Gertz, Suzanne R. Hayman, MD, William Hogan, MD, David J Inwards, Patrick L Johnston, MD, PhD, Shaji Kumar, MD, Martha Q. Lacy, MD, Mark R. Litzow, MD, Luis Porrata, MD, Robert Wolf, PharmD, Teresa Miceli, Jeff Winters

Blood (2009) 114 (22): 3211.

https://doi.org/10.1182/blood.V114.22.3211.3211

Published: 2009

Journal Articles

Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor Activity

Holbrook Kohrt, MD, Brit Turnbull, PhD, G. Laport, MD, D. Miklos, MD, PhD, J. Shizuru, MD, PhD, L. Johnston, MD, S. Arai, MD, W. K. Weng, MD, PhD, J. Benjamin, MD, PhD, K. Blume, MD, R. Negrin, MD, P. Lavori, PhD, S. Strober, MD, R. Lowsky, MD

Blood (2008) 112 (11): 3310.

https://doi.org/10.1182/blood.V112.11.3310.3310

Published: 2008

Journal Articles

The Presence of Central Nervous System Disease at Diagnosis in Pediatric Acute Myeloid Leukemia Does Not Affect Outcome.

Donna L. Johnston, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Beverly J. Lange, MD, William G. Woods, MD

Blood (2007) 110 (11): 1827.

https://doi.org/10.1182/blood.V110.11.1827.1827

Published: 2007

NARROW

The Effect of Traumatic Diagnostic Lumbar Puncture in De Novo Pediatric Acute Myeloid Leukemia - a Report from the Children's Oncology Group

Outcome of Pediatric Patients with Acute Myeloid Leukemia and -5/5q-Abnormalities Enrolled On Five Children's Oncology Group Acute Myeloid Leukemia Treatment Protocols

A Phase I/II Trial of Lenalidomide and RCHOP (R2CHOP) in Patients with Newly Diagnosed Diffuse Large B -Cell (DLBCL) and Follicular Grade 3 Lymphoma.

MYC Translocations Are Associated with Poor Overall Survival in DLBCL Patients in Both the Chemotherapy and Immunochemotherapy Eras.

Absolute Lymphocyte Count Assessed During Routine Follow-up Is a Risk Factor for Relapse Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Patients with Diffuse Large B-Cell Lymphoma.

A Risk Adapted Approach Utilizing Plerixafor in Autologous Peripheral Blood Stem Cell Mobilization.

Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor Activity

The Presence of Central Nervous System Disease at Diagnosis in Pediatric Acute Myeloid Leukemia Does Not Affect Outcome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only